Rhode Island Mobile Methadone Unit Shows Promise as 'Lifeline on Wheels'

A converted bus parked on a Woonsocket, Rhode Island street may represent one of the most promising innovations in the fight against the nation's deadliest drug crisis. A study published Friday in Addiction Science & Clinical Practice offers the most detailed examination to date of how mobile health units delivering medications for opioid use disorder function on the ground—documenting both their life-saving reach and the structural obstacles that threaten their survival.

The research, led by Augustine Kang of Boston Children's Hospital and Amelia Bailey of the Brown University School of Public Health, examined a mobile unit launched in July 2022 by CODAC Behavioral Healthcare, Rhode Island's largest provider of opioid treatment services. The unit operates as both a fully licensed opioid treatment program prescribing and dispensing medications six days a week, and as a community outreach service providing harm reduction supplies and counseling in under-resourced areas.

Reaching patients the system has failed

Between August and November 2024, researchers conducted semi-structured interviews with 15 stakeholders including mobile unit staff, organizational leadership, community partners, and a representative of the State Opioid Treatment Authority. The findings reveal an intervention that is simultaneously indispensable and precarious.

Stakeholders overwhelmingly endorsed the mobile unit as critical for reaching people whom traditional treatment has failed: those experiencing homelessness, economic instability, and transportation barriers that make daily visits to fixed clinics nearly impossible. Because federal regulations require in-person contact to initiate methadone treatment, people who are unhoused or transient often cannot access care at all. The mobile unit dissolves that barrier by bringing dosing, assessment, and intake directly into the neighborhoods where patients live.

The unit's value extends beyond medication. Staff described it as a comprehensive health hub offering blood pressure checks, wound care, clean needle and wound kits, and referrals to primary care for unmanaged chronic conditions like hypertension and diabetes. Many patients arrive with years of neglected medical needs, and the mobile unit serves as their re-entry point into the broader health system.

Building relationships, not just dispensing medication

Unlike conventional clinics where patients describe a culture of arriving, dosing, and leaving, the mobile unit's compact environment allows staff to know patients by name and build therapeutic rapport more quickly. Participants credited this familiarity with keeping people engaged in care even during periods of active substance use, describing a welcoming, nonjudgmental "family-oriented environment."

The ability to earn take-home doses of methadone emerged as one of the strongest retention tools, giving patients a tangible goal and growing sense of autonomy. Staff with years of clinical experience described patients regaining "breathing room"—freedom from the daily cycle of withdrawal and drug-seeking that allowed them to rebuild families, secure employment, and escape legal entanglements. Several recounted patients bringing parents, children, and partners into treatment, breaking cycles of generational addiction.

Obstacles to sustainability

Yet the study is equally candid about forces working against the unit. Staffing shortages loomed over nearly every conversation: the unit is not fully staffed, and counseling and case management services are provided by staff rotated in from Providence rather than a dedicated mobile team. Low insurance reimbursement rates and the precarious nature of grant funding left participants worried about long-term sustainability.

External resistance proved equally formidable. Stakeholders described political opposition from municipal officials who attempted to use zoning ordinances to shut down services, requiring legal intervention to resolve. Law enforcement activity near treatment sites—such as traffic stops targeting patients arriving for care—forced some patients to weigh the risk of arrest against their need for medication.

Remarkably, the study also documents a counter-trend: through proactive engagement and education, staff built relationships with police departments, and in some cases officers began referring individuals to the unit instead of arresting them. Over time, sustained operation softened community stigma, as residents observed that the unit did not produce the negative consequences they had feared.

National expansion, untapped potential

The number of federally approved methadone mobile units in the United States has grown from just 8 in 2022 to 64 by early 2025, following the reversal of a Drug Enforcement Administration moratorium that had blocked expansion since 2007. Yet a recent scoping review cited in the study found that such units remain under-utilized, suggesting both unmet need and unrealized potential.

Stakeholders offered a roadmap for realizing that potential: better marketing and outreach including social media presence; large-scale de-stigmatization campaigns framing addiction as a medical condition; expanded staffing; improved language access; stronger partnerships with housing services and food pantries; and above all, stable long-term funding. Some participants also envisioned expanded services such as community drug-checking for polysubstance users—a ground-level harm reduction tool suited to the modern, fentanyl-saturated drug supply.

Whether these lifelines on wheels become a permanent fixture of the American addiction treatment landscape will depend less on clinical evidence—which increasingly supports them—than on the funding streams, policies, and political will required to keep the engines running.